Back
Compass Therapeutics Stock Predictions
Disrupting a Trillion-Dollar Industry
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.
Sell
48
CMPX
Compass Therapeutics
Last Price:
$2.11
Seasonality Move:
-7.69%
7 Day Trial
ALL ACCESS PASS
$
7
The Future of Housing Is Being Built Now
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.Compass Therapeutics Stock Forecast
-
Is Compass Therapeutics Stock Undervalued?The current Compass Therapeutics [CMPX] share price is $2.06. The Score for CMPX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
CMPX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Compass Therapeutics Stock Go Up Next Year?
Data Unavailable
Compass Therapeutics Stock Rating
Data Unavailable
Compass Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
compasstherapeutics.com
52-Week Data
52-Week High:
4.08
52-Week Low:
0.77
Prediction Charts
Market Cap:
284.9M
Price in USD:
2.06
Volume:
387.4K
Beta:
1.19
Technical Analysis
SMA50:
1.96
SMA100:
2.32
SMA200:
1.94
52-Wk Change:
28.75%
Stock Predictions
-
Is Compass Therapeutics stock public?Yes, Compass Therapeutics is a publicly traded company.
-
What is the Compass Therapeutics stock quote today?The Compass Therapeutics stock price is 2.06 USD today.
-
How to buy Compass Therapeutics stock online?You can buy Compass Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| May-2 | 1.85 | 1.89 | 1.94 | 1.84 |
| May-5 | 1.87 | 1.86 | 1.95 | 1.84 |
| May-6 | 1.81 | 1.69 | 1.85 | 1.67 |
| May-7 | 1.70 | 1.76 | 1.79 | 1.67 |
| May-8 | 1.68 | 1.78 | 1.81 | 1.67 |
| May-9 | 1.81 | 1.82 | 1.83 | 1.67 |
| May-12 | 1.84 | 2.01 | 2.02 | 1.84 |
| May-13 | 2.00 | 2.00 | 2.08 | 1.84 |
| May-14 | 2.00 | 2.00 | 2.01 | 1.95 |
| May-15 | 1.99 | 2.02 | 2.08 | 1.95 |
| May-16 | 2.04 | 2.10 | 2.13 | 2.00 |
| May-19 | 2.06 | 2.11 | 2.21 | 2.06 |
| May-20 | 2.13 | 2.10 | 2.22 | 2.09 |
| May-21 | 2.10 | 2.06 | 2.13 | 2.03 |
Compass Therapeutics Earnings
Data Unavailable
Compass Therapeutics Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.14 per share, and a decrease next year of $0.04 per share.
* Compass Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.